Zymeworks Inc. (ZYME)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.82 |
| Open | 5.73 |
| Bid | 6.02 x 900 |
| Ask | 6.15 x 1200 |
| Day's range | 5.61 - 6.08 |
| 52-week range | 4.56 - 39.41 |
| Volume | |
| Avg. volume | 1,766,998 |
| Market cap | 346.049M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Zymeworks Inc. (ZYME) Reports Q1 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) delivered earnings and revenue surprises of -22.68% and 49.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Zymeworks Inc. (ZYME) Surges 23.2%: Is This an Indication of Further Gains?
Zymeworks Inc. (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Motley Fool
Why Zymeworks Stock Is Rocketing Higher on Friday
New cancer trial results from the clinical-stage biopharmaceutical company inspired a juicy buyout offer.
© 2022 Yahoo. All rights reserved.
